| Primary |
| Cardiac Disorder |
25.0% |
| Constipation |
25.0% |
| Intracranial Aneurysm |
25.0% |
| Pelvic Pain |
25.0% |
|
| Cardiac Arrest |
25.0% |
| Drug Toxicity |
25.0% |
| Product Quality Issue |
25.0% |
| Respiratory Acidosis |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
50.2% |
| Drug Use For Unknown Indication |
12.9% |
| Ventricular Tachycardia |
7.2% |
| Foetal Exposure During Pregnancy |
5.5% |
| Status Epilepticus |
2.1% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Hypertension |
2.0% |
| Muscle Spasms |
1.8% |
| Depression |
1.6% |
| Psychotic Disorder |
1.6% |
| Myalgia |
1.5% |
| Ventricular Arrhythmia |
1.5% |
| Atrial Fibrillation |
1.3% |
| Back Pain |
1.3% |
| Convulsion |
1.3% |
| Pain |
1.3% |
| Parenteral Nutrition |
1.3% |
| Supplementation Therapy |
1.3% |
| Total Parenteral Nutrition |
1.3% |
| Pulmonary Arterial Hypertension |
1.1% |
|
| Completed Suicide |
13.8% |
| Urticaria |
8.8% |
| Ventricular Tachycardia |
8.8% |
| Shock |
6.3% |
| Dyspnoea |
5.0% |
| Memory Impairment |
5.0% |
| Premature Baby |
5.0% |
| Suicide Attempt |
5.0% |
| Vomiting |
5.0% |
| Death |
3.8% |
| Headache |
3.8% |
| Nausea |
3.8% |
| Pruritus |
3.8% |
| Tendon Pain |
3.8% |
| Transplant Failure |
3.8% |
| Ventricular Extrasystoles |
3.8% |
| Weight Increased |
3.8% |
| Diarrhoea |
2.5% |
| Hypotension |
2.5% |
| International Normalised Ratio Increased |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.9% |
| Drug Use For Unknown Indication |
10.5% |
| Hypertension |
5.6% |
| Prophylaxis |
4.1% |
| Pain |
3.9% |
| Supplementation Therapy |
2.8% |
| Rheumatoid Arthritis |
2.7% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Osteoporosis |
2.4% |
| Atrial Fibrillation |
2.0% |
| Depression |
2.0% |
| Vitamin Supplementation |
1.9% |
| Multiple Myeloma |
1.9% |
| Diabetes Mellitus |
1.9% |
| Crohn's Disease |
1.8% |
| Nausea |
1.6% |
| Mineral Supplementation |
1.5% |
| Blood Cholesterol Increased |
1.4% |
| Anxiety |
1.3% |
| Asthma |
1.3% |
|
| Vomiting |
13.9% |
| Weight Decreased |
8.3% |
| Weight Increased |
8.0% |
| Nausea |
5.6% |
| Drug Ineffective |
5.5% |
| Pain |
5.0% |
| Death |
4.9% |
| Urinary Tract Infection |
4.9% |
| Vision Blurred |
4.5% |
| Rash |
4.3% |
| Flushing |
4.0% |
| Pain In Extremity |
3.9% |
| Pneumonia |
3.9% |
| Pruritus |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Pyrexia |
3.3% |
| Tremor |
3.2% |
| Renal Failure |
3.1% |
| Somnolence |
3.1% |
| Fatigue |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
52.6% |
| Asthma |
10.5% |
| Blood Cholesterol Increased |
5.3% |
| Erectile Dysfunction |
5.3% |
| Gastrointestinal Disorder |
5.3% |
| Gastrooesophageal Reflux Disease |
5.3% |
| Parkinson's Disease |
5.3% |
| Smoking Cessation Therapy |
5.3% |
| Supplementation Therapy |
5.3% |
|
| Drug Interaction |
37.5% |
| Blood Glucose Increased |
12.5% |
| Influenza Like Illness |
12.5% |
| Myocardial Infarction |
12.5% |
| Nausea |
12.5% |
| Pruritus Generalised |
12.5% |
|
